Russell is a seasoned executive with over 25 years experience in finance, acquisitions, partnering, marketing and operations with companies ranging from start-ups to a Fortune 5. He has over 14 years CFO experience for life science technology companies, with more than 10 years in public life science companies.
Russell has significant private equity, public market, operations and transaction experience with both public and private companies. He comes to BioTime from Proove Biosciences, Inc. where he had served as Chief Financial Officer. Russell was previously the Senior Vice President, Chief Financial Officer and Secretary of Aeolus Pharmaceuticals, Inc., a Southern California-based biotechnology company with over $150M in government funding. Prior to joining Aeolus, Russell was Senior Vice President and Chief Business Officer of Spectrum Pharmaceuticals, where he led global strategy, mergers and acquisitions, licensing, fund-raising and investor and public relations. At Spectrum he completed numerous financings as well as one of 2008’s largest biopharma partnering transactions for a non-platform technology. Previously, Russell was Chief Financial Officer at Hana Biosciences, Inc., where he led the process of bringing the Company public and completed two financings. Prior to Hana, he was Partner and Chief Financial Officer of Asset Management Company, one of Silicon Valley’s oldest and most respected venture capital firms, founded by Pitch Johnson, where he oversaw the financial and administrative functions, public and private portfolios, and aviation operations. He also managed the Johnson family office and the Franklin & Catherine Johnson Foundation.
Russell has a degree in Economics from Claremont McKenna College and an MBA from the Stanford Graduate School of Business.